HMGB1 Acts in Synergy with Lipopolysaccharide in Activating Rheumatoid Synovial Fibroblasts via p38 MAPK and NF-κB Signaling Pathways

Synovial fibroblasts (SF) play a central role in the inflammatory and destructive process in rheumatoid arthritis (RA). High-mobility group box chromosomal protein 1 (HMGB1) or lipopolysaccharide (LPS) alone failed to induce significant changes in proliferation of cultured SF from RA patients, but p...

Full description

Saved in:
Bibliographic Details
Main Authors: Zheng-Wen He, Yang-Hua Qin, Zhi-Wei Wang, Yan Chen, Qian Shen, Sheng-Ming Dai
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2013/596716
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561023698075648
author Zheng-Wen He
Yang-Hua Qin
Zhi-Wei Wang
Yan Chen
Qian Shen
Sheng-Ming Dai
author_facet Zheng-Wen He
Yang-Hua Qin
Zhi-Wei Wang
Yan Chen
Qian Shen
Sheng-Ming Dai
author_sort Zheng-Wen He
collection DOAJ
description Synovial fibroblasts (SF) play a central role in the inflammatory and destructive process in rheumatoid arthritis (RA). High-mobility group box chromosomal protein 1 (HMGB1) or lipopolysaccharide (LPS) alone failed to induce significant changes in proliferation of cultured SF from RA patients, but premixed HMGB1 with LPS (HMGB1-LPS) significantly facilitated SF proliferation. HMGB1 alone failed to induce IL-6, MMP-3, and MMP-13 production in cultured SF but greatly enhanced LPS-induced expression of IL-6, MMP-3, and MMP-13 at both mRNA and protein levels. HMGB1-LPS synergistically upregulated TLR4 and receptor for advanced glycation endproducts (RAGE) expression on the surface of SF. Both blockers of TLR4 and RAGE significantly inhibited the synergistic effects of HMGB1-LPS on the production of IL-6 and MMPs, but blocking antibodies to TLR2 failed. HMGB1-LPS synergistically increased intracellular levels of phosphorylated p38 and phosphorylated IκB. Furthermore, both NF-κB inhibitor Bay11-7085 and p38 inhibitor SB203580 significantly suppressed the enhanced production of IL-6 and MMPs induced by HMGB1-LPS. In conclusion, HMGB1 acts in synergy with LPS to upregulate TLR4 and RAGE expression on the surface of SF in RA and then to augment IL-6, MMP-3, and MMP-13 production, which depends on p38 MAPK and NF-κB activation.
format Article
id doaj-art-7df8984e673d485ab21c60aaef22c21f
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-7df8984e673d485ab21c60aaef22c21f2025-02-03T01:26:08ZengWileyMediators of Inflammation0962-93511466-18612013-01-01201310.1155/2013/596716596716HMGB1 Acts in Synergy with Lipopolysaccharide in Activating Rheumatoid Synovial Fibroblasts via p38 MAPK and NF-κB Signaling PathwaysZheng-Wen He0Yang-Hua Qin1Zhi-Wei Wang2Yan Chen3Qian Shen4Sheng-Ming Dai5Department of Laboratory Diagnosis, Changhai Hospital, Second Military Medical University, 168 Changhai Road, Shanghai 200433, ChinaDepartment of Laboratory Diagnosis, Changhai Hospital, Second Military Medical University, 168 Changhai Road, Shanghai 200433, ChinaDepartment of Orthopedics, Changhai Hospital, Second Military Medical University, Shanghai 200433, ChinaDepartment of Laboratory Diagnosis, Changhai Hospital, Second Military Medical University, 168 Changhai Road, Shanghai 200433, ChinaDepartment of Laboratory Diagnosis, Changhai Hospital, Second Military Medical University, 168 Changhai Road, Shanghai 200433, ChinaDepartment of Rheumatology & Immunology, Changhai Hospital, Second Military Medical University, 168 Changhai Road, Shanghai 200433, ChinaSynovial fibroblasts (SF) play a central role in the inflammatory and destructive process in rheumatoid arthritis (RA). High-mobility group box chromosomal protein 1 (HMGB1) or lipopolysaccharide (LPS) alone failed to induce significant changes in proliferation of cultured SF from RA patients, but premixed HMGB1 with LPS (HMGB1-LPS) significantly facilitated SF proliferation. HMGB1 alone failed to induce IL-6, MMP-3, and MMP-13 production in cultured SF but greatly enhanced LPS-induced expression of IL-6, MMP-3, and MMP-13 at both mRNA and protein levels. HMGB1-LPS synergistically upregulated TLR4 and receptor for advanced glycation endproducts (RAGE) expression on the surface of SF. Both blockers of TLR4 and RAGE significantly inhibited the synergistic effects of HMGB1-LPS on the production of IL-6 and MMPs, but blocking antibodies to TLR2 failed. HMGB1-LPS synergistically increased intracellular levels of phosphorylated p38 and phosphorylated IκB. Furthermore, both NF-κB inhibitor Bay11-7085 and p38 inhibitor SB203580 significantly suppressed the enhanced production of IL-6 and MMPs induced by HMGB1-LPS. In conclusion, HMGB1 acts in synergy with LPS to upregulate TLR4 and RAGE expression on the surface of SF in RA and then to augment IL-6, MMP-3, and MMP-13 production, which depends on p38 MAPK and NF-κB activation.http://dx.doi.org/10.1155/2013/596716
spellingShingle Zheng-Wen He
Yang-Hua Qin
Zhi-Wei Wang
Yan Chen
Qian Shen
Sheng-Ming Dai
HMGB1 Acts in Synergy with Lipopolysaccharide in Activating Rheumatoid Synovial Fibroblasts via p38 MAPK and NF-κB Signaling Pathways
Mediators of Inflammation
title HMGB1 Acts in Synergy with Lipopolysaccharide in Activating Rheumatoid Synovial Fibroblasts via p38 MAPK and NF-κB Signaling Pathways
title_full HMGB1 Acts in Synergy with Lipopolysaccharide in Activating Rheumatoid Synovial Fibroblasts via p38 MAPK and NF-κB Signaling Pathways
title_fullStr HMGB1 Acts in Synergy with Lipopolysaccharide in Activating Rheumatoid Synovial Fibroblasts via p38 MAPK and NF-κB Signaling Pathways
title_full_unstemmed HMGB1 Acts in Synergy with Lipopolysaccharide in Activating Rheumatoid Synovial Fibroblasts via p38 MAPK and NF-κB Signaling Pathways
title_short HMGB1 Acts in Synergy with Lipopolysaccharide in Activating Rheumatoid Synovial Fibroblasts via p38 MAPK and NF-κB Signaling Pathways
title_sort hmgb1 acts in synergy with lipopolysaccharide in activating rheumatoid synovial fibroblasts via p38 mapk and nf κb signaling pathways
url http://dx.doi.org/10.1155/2013/596716
work_keys_str_mv AT zhengwenhe hmgb1actsinsynergywithlipopolysaccharideinactivatingrheumatoidsynovialfibroblastsviap38mapkandnfkbsignalingpathways
AT yanghuaqin hmgb1actsinsynergywithlipopolysaccharideinactivatingrheumatoidsynovialfibroblastsviap38mapkandnfkbsignalingpathways
AT zhiweiwang hmgb1actsinsynergywithlipopolysaccharideinactivatingrheumatoidsynovialfibroblastsviap38mapkandnfkbsignalingpathways
AT yanchen hmgb1actsinsynergywithlipopolysaccharideinactivatingrheumatoidsynovialfibroblastsviap38mapkandnfkbsignalingpathways
AT qianshen hmgb1actsinsynergywithlipopolysaccharideinactivatingrheumatoidsynovialfibroblastsviap38mapkandnfkbsignalingpathways
AT shengmingdai hmgb1actsinsynergywithlipopolysaccharideinactivatingrheumatoidsynovialfibroblastsviap38mapkandnfkbsignalingpathways